Benign neoplasm of other specified female genital organs
ICD-10 D28.7 is a billable code used to indicate a diagnosis of benign neoplasm of other specified female genital organs.
Benign neoplasms of the female genital organs encompass a variety of non-cancerous tumors that can occur in various structures such as the vulva, vagina, cervix, uterus, and ovaries. These neoplasms may include fibromas, adenomas, and lipomas, among others. They are typically asymptomatic but can sometimes present with symptoms such as abnormal bleeding, pelvic pain, or pressure symptoms depending on their size and location. Diagnosis is often made through imaging studies such as ultrasound or MRI, and histological examination may be required for definitive diagnosis. Management usually involves monitoring for changes in size or symptoms, and surgical intervention may be necessary if the neoplasm causes significant discomfort or complications. Follow-up care is essential to ensure that the neoplasm remains benign and does not progress to malignancy. Regular gynecological examinations are recommended for early detection and management of any changes in the neoplasm's characteristics.
Detailed descriptions of the neoplasm, including size, location, and any symptoms.
Management of asymptomatic fibroids, evaluation of abnormal uterine bleeding.
Ensure that the documentation clearly states the benign nature of the neoplasm to avoid misclassification.
Histopathological reports that confirm the benign nature of the neoplasm.
Review of biopsy specimens from female genital organs.
Accurate reporting of histological findings is crucial for proper coding.
Performed for symptomatic benign neoplasms of the uterus.
Operative report detailing the indication for surgery and findings.
Gynecologists should ensure that the diagnosis aligns with the procedure performed.
Common symptoms may include abnormal bleeding, pelvic pain, or pressure symptoms, but many benign neoplasms are asymptomatic.
Patients should have regular follow-ups, typically annually or as needed based on symptoms or changes in the neoplasm.
